Influential factors in bisphosphonates for periprosthetic bone loss after total joint arthroplasty

被引:0
作者
Lin, Tiao [1 ]
Zuo, Xi [2 ]
Yan, Shi-Gui [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China
[2] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; MINERAL DENSITY; ALENDRONATE; METAANALYSIS; ETIDRONATE; THERAPY; TRIAL;
D O I
10.1007/s00776-013-0500-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
引用
收藏
页码:199 / 203
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2008, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
[2]   Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: Prospective randomized double-blind study [J].
Arabmotlagh, Mohammad ;
Rittmeister, Markus ;
Hennigs, Thorsten .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2006, 24 (07) :1336-1341
[3]   Changes of Femoral Periprosthetic Bone Mineral Density 6 Years after Treatment with Alendronate following Total Hip Arthroplasty [J].
Arabmotlagh, Mohammad ;
Pilz, Mathias ;
Warzecha, Joerg ;
Rauschmann, Michael .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2009, 27 (02) :183-188
[4]   Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty -: A meta-analysis [J].
Bhandari, M ;
Bajammal, S ;
Guyatt, GH ;
Griffith, L ;
Busse, JW ;
Schünemann, H ;
Einhorn, TA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (02) :293-301
[5]   Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials [J].
Lin, T. ;
Yan, S. -G. ;
Cai, X. -Z. ;
Ying, Z. -M. .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (06) :1823-1834
[6]   Clinical and radiological outcome of total hip replacement five years after pamidronate therapy - A trial extension [J].
Shetty, N. ;
Hamer, A. J. ;
Stockley, I. ;
Eastell, R. ;
Wilkinson, J. M. .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2006, 88B (10) :1309-1315
[7]   Effect of alendronate on periprosthetic bone loss after total knee arthroplasty:: A one-year, randomized, controlled trial of 19 patients [J].
Soininvaara, TA ;
Jurvelin, JS ;
Miettinen, HJA ;
Suomalainen, OT ;
Alhava, EM ;
Kröger, PJ .
CALCIFIED TISSUE INTERNATIONAL, 2002, 71 (06) :472-477
[8]   Impact of covert duplicate publication on meta-analysis: a case study [J].
Tramer, MR ;
Reynolds, DJM ;
Moore, RA ;
McQuay, HJ .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :635-640
[9]   Decreased Periprosthetic Bone Loss in Patients Treated with Clodronate: A 1-Year Randomized Controlled Study [J].
Trevisan, C. ;
Ortolani, S. ;
Romano, P. ;
Isaia, G. ;
Agnese, L. ;
Dallari, D. ;
Grappiolo, G. ;
Cherubini, R. ;
Massari, L. ;
Bianchi, G. .
CALCIFIED TISSUE INTERNATIONAL, 2010, 86 (06) :436-446
[10]   Three-year changes inbone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty - A prospective, randomized study [J].
Wang, CJ ;
Wang, JW ;
Ko, JY ;
Weng, LH ;
Huang, CC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (02) :267-272